Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.
about
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesPreparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombusMultiscale observation of biological interactions of nanocarriers: from nano to macro.Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosisArchitectonics of phage-liposome nanowebs as optimized photosensitizer vehicles for photodynamic cancer therapy.Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo.Targeted thrombolysis strategies for neuroprotective effectImaging metastasis using an integrin-targeting chain-shaped nanoparticle.Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.Synergistically enhanced selective intracellular uptake of anticancer drug carrier comprising folic acid-conjugated hydrogels containing magnetite nanoparticles.Role of nanocarrier systems in cancer nanotherapy.Using liposomes to target infection and inflammation induced by foreign body injuries or medical implants.Mesenchymal stem cell-based tissue engineering for chondrogenesis.Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.A platelet-inspired paradigm for nanomedicine targeted to multiple diseases.Hemostatic strategies for traumatic and surgical bleeding.Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy.Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.Translational initiatives in thrombolytic therapy.In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.Optimization of RGD-modified Nano-liposomes Encapsulating Eptifibatide.Advantages of RGD peptides for directing cell association with biomaterials.Targeted antithrombotic protein micelles.Peptide Mimetic Drugs for Modulating Thrombosis and Hemostasis.Antibody-targeted drug delivery to injured arteries using layered double hydroxide nanoparticles.Encapsulation of eptifibatide in RGD-modified nanoliposomes improves platelet aggregation inhibitory activity.Development of liposomal nanoconstructs targeting P-selectin (CD62P)-expressing cells by using a sulfated derivative of sialic acid.Targeted delivery of thrombolytic agents: role of integrin receptors
P2860
Q26995399-BB0FF730-F8F1-4C46-A8CE-D191E31E4C41Q30448359-193283D7-E16F-4E7C-A59F-5CFEA91C5077Q30474384-060A6609-63EF-4BD8-B760-159ACEDED0BAQ31028062-EC937DF2-5EEC-48A0-AB82-F47602CF0114Q33679580-728B6FB4-DBF9-42A4-A897-DF85DC351036Q33762115-8A4BD7A6-12A4-493A-A59B-4300AE44AB50Q34044872-72D88B0D-C284-47FD-8300-AEDD6328C4C1Q34163191-18C0D1C9-51DB-4B98-BAD2-CE4D0E58B7DCQ36366404-584AA950-D0FF-45E9-B41D-E492A5CD4867Q37249147-89F5AB26-C7F6-414F-8BDD-0C3843871352Q37572760-367AFD47-D605-4A5B-B683-6ABCCDBC92A3Q37595258-D65FF807-D7D3-4A1D-90FC-28F70CB35646Q37622867-ACE29E62-C5D6-4CB7-BF8B-CD15B833A903Q37790712-2795D7F8-D6BD-46A4-8379-C069429060DFQ37946878-6B7A2DB1-12F5-45EE-80A4-3DED8D78D8BAQ38105137-AF151D15-98D6-47D5-9A30-CFA8685CE57BQ38145567-EC530961-CB5C-46B2-BF3B-C44BE0EAE053Q38168784-D1AF5486-D65E-4005-B3BF-FA8DF0E65DC0Q38527633-DFAE2B3B-0C53-4F1B-A1C6-A3795EA94219Q38837337-A6E1ED85-C740-48FD-9248-918D13982FB1Q39100187-F4314311-26B5-4F64-ACAF-A1DF9E263E0EQ40025769-69FFB63F-FD88-42AD-80A1-D8668ADCCF8FQ41674171-2341B70A-697B-4FA7-846C-4CACBADACD30Q41884886-70E6C09C-905E-469E-9C3E-11A08233CD73Q42617570-36511A67-248F-4C73-970A-BB92404AE2A2Q44874794-6910E77F-2417-40F5-A319-F4D2D68CB297Q50487524-29AE2D10-CE12-4773-9DB0-41CD5B974F31Q51124774-6CFF30F6-9483-4C1E-8EEF-56C23A9AF840Q51748923-1933D45C-BC98-40DF-A504-E53994BFDB53Q56897486-34DB7D33-E7CF-42E2-9D5B-A6B7AD064F71
P2860
Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Affinity manipulation of surfa ...... osomes to activated platelets.
@ast
Affinity manipulation of surfa ...... osomes to activated platelets.
@en
Affinity manipulation of surfa ...... osomes to activated platelets.
@nl
type
label
Affinity manipulation of surfa ...... osomes to activated platelets.
@ast
Affinity manipulation of surfa ...... osomes to activated platelets.
@en
Affinity manipulation of surfa ...... osomes to activated platelets.
@nl
prefLabel
Affinity manipulation of surfa ...... osomes to activated platelets.
@ast
Affinity manipulation of surfa ...... osomes to activated platelets.
@en
Affinity manipulation of surfa ...... osomes to activated platelets.
@nl
P2093
P2860
P1433
P1476
Affinity manipulation of surfa ...... osomes to activated platelets.
@en
P2093
Anirban S Gupta
Guofeng Huang
Marc S Penn
Rekha Srinivasan
Roger E Marchant
Zhongmin Zhou
P2860
P304
P356
10.1016/J.BIOMATERIALS.2007.12.015
P577
2008-01-14T00:00:00Z